We are live on ! Find out more
CG

Column Group Portfolio holdings

AUM $88.1M
1-Year Est. Return 148.03%
This Fund
S&P 500
This Quarter Est. Return
+40.47%
1 Year Est. Return
+148.03%
3 Year Est. Return
+95.12%
5 Year Est. Return
+23.89%
10 Year Est. Return
–
AUM
$101M
AUM Growth
+$17.9M
Cap. Flow
-$10.4M
Cap. Flow %
-10.34%
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
1
Reduced
–
Closed
2

Top Buys

Rank Stock Value
1
SRZN icon
Surrozen
SRZN
+$1.57M

Top Sells

Rank Stock Value
1
TNYA icon
Tenaya Therapeutics
TNYA
+$6.69M
2
RAPT
RAPT Therapeutics
RAPT
+$5.29M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SRZN icon
1
Surrozen
SRZN
$282M
$55.8M 55.45%
1,916,950
+65,600
+4% +$1.57M
ORIC icon
2
Oric Pharmaceuticals
ORIC
$1.44B
$44.9M 44.55%
3,540,777
– –
RVMD icon
3
Revolution Medicines
RVMD
$43.7B
$4.47K ﹤0.01%
46
– –
RAPT
4
DELISTED
RAPT Therapeutics
RAPT
– –
-156,270
Closed -$5.29M
TNYA icon
5
Tenaya Therapeutics
TNYA
$163M
– –
-9,400,290
Closed -$6.69M

Similar funds

PIS
POM Investment Strategies Raleigh, North Carolina $88.3M AUM 15.23% 1-Year Est. Return
FWM
FSR Wealth Management Elmhurst, Illinois $87.8M AUM 10.63% 1-Year Est. Return
WP
Walleye Partners Madison, Wisconsin $87.7M AUM
SHCM
Stone House Capital Management Bay Harbor Islands, Florida $88.5M AUM 149.16% 1-Year Est. Return
YIM
Yoffe Investment Management Lemoyne, Pennsylvania $87.4M AUM 30.8% 1-Year Est. Return
VPW
Variant Private Wealth Tysons, Virginia $88.9M AUM 25.07% 1-Year Est. Return
LC
Luminist Capital Grand Rapids, Michigan $89M AUM 17.66% 1-Year Est. Return
BI
Bradyco Inc Cambridge, Massachusetts $87.2M AUM 8.85% 1-Year Est. Return

Column Group's Q1 2026 Portfolio in Review

As of Q1 2026, Column Group held 5 positions worth $101M, up 22% from $82.8M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Column Group withdrew a net $10.4M in Q1 2026, closing 2 positions. Its most notable exit was Tenaya Therapeutics, an estimated $6.69M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

Against the trend, Column Group added an estimated $1.57M to Surrozen.

  • Column Group added most to Surrozen in Q1 2026, an estimated $1.57M increase.
  • Column Group fully exited Tenaya Therapeutics in Q1 2026, selling an estimated $6.69M.
  • Column Group's ten largest holdings make up 100% of its $101M portfolio in Q1 2026.
  • Column Group opened 0 new positions and closed 2 in Q1 2026.
  • Column Group's portfolio value rose 22% quarter-over-quarter to $101M.

Based on Column Group's 13F filing for Q1 2026, filed 18 May 2026.